# Adare Pharmaceuticals Srl – FDA Inspection, Oct 28, 2022

Source: https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-srl/a51f1774-c0ae-4df7-a388-c9f599cf739a
Source feed: FDA_Inspections

> FDA inspection 1204801 of Adare Pharmaceuticals Srl, October 28, 2022. Classification: Voluntary Action Indicated (VAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204801
- Company Name: Adare Pharmaceuticals Srl
- Inspection Date: 2022-10-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1098299 - 2018-04-13
- [FDA Inspection 1006241 - 2017-02-24](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-srl/75dde054-ec24-489f-a35c-ec53c5804795)
- [FDA Inspection 883317 - 2014-05-30](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-srl/6410e002-4f7f-4564-b426-153943490d32)
- FDA Inspection 793805 - 2012-07-19
- FDA Inspection 622477 - 2009-10-09

Company: https://www.keypedia.com/companies/adare-pharmaceuticals-srl/d3b29a2a-343c-45ab-9ab7-0159306f853d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c